£7.8M
The London-based biotechnology firm raised the capital from backers including Cantos Ventures and Y Combinator.
Sixfold Bioscience develops programmable delivery systems for RNA therapeutics.
Sixfold Bioscience designs programmable drug delivery systems by combining advanced chemistry and computation. The company focuses on expanding RNA therapeutics beyond the liver.
Cash at bank
Net current assets
Total assets less current liabilities
Shareholders' funds
Current assets
Employees
Cash, assets and headcount from Sixfold Bioscience's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Perdrix Rosell
Co-founder
The London-based biotechnology firm raised the capital from backers including Cantos Ventures and Y Combinator.